AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
KAI 12L, the AI powering Kardia 12L, adds five new detections to further expand diagnostic capabilities for the world's first ...
Medical Device Network on MSN
AliveCor secures FDA approval for next-generation Kardia 12L ECG system
The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
PulseAI's technology, trained on large-scale ECG datasets and validated in partnership with some of the world's leading institutions across Europe and the United States, promises to bring the power of ...
The Lown-Ganong-Levine (LGL) syndrome occurs when an accessory pathway is congenitally present that directly connects the atria to the ventricles, bypassing the AV node similar to the ...
In patients with symptoms such as irregular heartbeats, dizziness, or fainting, or in individuals that physicians suspect may have atrial fibrillation, many days of ECGs may be required for diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback